Meridian Clinical Research

Pharmaceutical ManufacturingNebraska, United States201-500 Employees

Meridian Clinical Research partners with pharmaceutical and biotechnology companies to study new drugs, medical devices, and diagnostics that could improve human health. Founded in 1999 and headquartered in Omaha, Nebraska, the organization conducts Phase 1 through 4 trials at investigative sites across North America, with a focus on high-volume vaccine studies. It maintains proprietary patient databases and leverages physician practice data to identify potential study participants, enabling rapid data turnaround and fast start-up.

Its client base consists of sponsors seeking broad therapeutic coverage and access to diverse patient populations, with additional support through call centers that aid recruitment, retention, and follow-up. The company operates a geographically and demographically diverse site network, which facilitates prompt study infrastructure and access to potential participants, and Meridian is the largest member of the Platinum Research Network, providing access to more than 47 million patients globally. In December 2022, Meridian Clinical Research was acquired by Velocity Clinical Research, integrating Meridian into Velocity's platform of research sites.

Sign up for free to view info

Email Format Employee directory